| Authors: |
de Bock CE; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia; School of Clinical Medicine, Medicine and Health, UNSW Sydney, Sydney, Australia., Bridge KS; Centre for Blood Research, York Biomedical Research Institute, University of York, United Kingdom., van Gastel N; de Duve Institute, UCLouvain, Brussels, Belgium; WELBIO Department, WEL Research Institute, Wavre, Belgium., Gleitz HFE; Department of Developmental Biology, Erasmus Medical Center, Rotterdam, The Netherlands., Kats L; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; The Sir Peter MacCallum; Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., King KY; Department of Pediatrics, Division of Infectious Diseases, Baylor College of Medicine, Houston, TX., Machlus KR; Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School, Boston, MA., Psaila B; MRC Weatherall Institute of Molecular Medicine and Ludwig Institute for Cancer Research, University of Oxford, United Kingdom., Scanlon V; Center for Regenerative Medicine and Skeletal Development, UConn Health, Farmington, CT; Laboratory Medicine, Yale School of Medicine, New Haven, CT., Souroullas GP; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO., Kokkaliaris KD; Dr. Senckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt am Main, Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Quantitative Spatial Cancer Biology Laboratory, and German Cancer Research Center (DKFZ), Heidelberg, Germany; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt am Main, Germany. Electronic address: kokkaliaris@med.uni-frankfurt.de. |
